226 related articles for article (PubMed ID: 1586597)
1. Tumour growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry.
Forster G; Cooke TG; Cooke LD; Stanton PD; Bowie G; Stell PM
Br J Cancer; 1992 May; 65(5):698-702. PubMed ID: 1586597
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of cell kinetics in head and neck squamous carcinoma: the relationship to tumour factors and survival.
Cooke LD; Cooke TG; Forster G; Jones AS; Stell PM
Br J Cancer; 1994 Apr; 69(4):717-20. PubMed ID: 8142259
[TBL] [Abstract][Full Text] [Related]
3. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck.
Bennett MH; Wilson GD; Dische S; Saunders MI; Martindale CA; Robinson BM; O'Halloran AE; Leslie MD; Laing JH
Br J Cancer; 1992 Jun; 65(6):870-8. PubMed ID: 1616858
[TBL] [Abstract][Full Text] [Related]
4. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
[TBL] [Abstract][Full Text] [Related]
5. [Cell kinetic analysis and treatment planning in epidermoid tumors of the head and neck].
Margarino G; Scala M; Schenone G; Mereu P; Corvo R; Sanguineti G; Giaretti W; Geido E; Orecchia R; Meszaros P
Acta Otorhinolaryngol Ital; 1992; 12(5):421-33. PubMed ID: 1303006
[TBL] [Abstract][Full Text] [Related]
6. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
[TBL] [Abstract][Full Text] [Related]
7. Radiation effects on S-phase duration, labelling index, potential doubling time and DNA distribution in head and neck cancer xenografts.
Zätterström UK; Engellau J; Johansson MC; Wennerberg J; Kjellén E
Acta Oncol; 1995; 34(2):205-11. PubMed ID: 7718258
[TBL] [Abstract][Full Text] [Related]
8. Cellular kinetics in rectal cancer.
Terry NH; Meistrich ML; Roubein LD; Lynch PM; Dubrow RA; Rich TA
Br J Cancer; 1995 Aug; 72(2):435-41. PubMed ID: 7640229
[TBL] [Abstract][Full Text] [Related]
9. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy.
Wilson GD; Dische S; Saunders MI
Radiother Oncol; 1995 Sep; 36(3):189-97. PubMed ID: 8532905
[TBL] [Abstract][Full Text] [Related]
10. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry.
Wilson GD; McNally NJ; Dische S; Saunders MI; Des Rochers C; Lewis AA; Bennett MH
Br J Cancer; 1988 Oct; 58(4):423-31. PubMed ID: 3207597
[TBL] [Abstract][Full Text] [Related]
11. Cell kinetics of head and neck squamous cell carcinomas. Prognostic implications.
Nylander K; Anneroth G; Gustafsson H; Roos G; Stenling R; Zackrisson B
Acta Oncol; 1994; 33(1):23-8. PubMed ID: 8142119
[TBL] [Abstract][Full Text] [Related]
12. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
Corvò R; Giaretti W; Margarino G; Danova M; Vitale V
Radiol Med; 1991; 82(1-2):147-52. PubMed ID: 1896568
[TBL] [Abstract][Full Text] [Related]
13. Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer.
Corvò R; Paoli G; Giaretti W; Sanguineti G; Geido E; Benasso M; Margarino G; Vitale V
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):57-63. PubMed ID: 10758305
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours.
Wilson GD; Saunders MI; Dische S; Daley FM; Robinson BM; Martindale CA; Joiner B; Richman PI
Cell Prolif; 1996 Mar; 29(3):141-52. PubMed ID: 8652743
[TBL] [Abstract][Full Text] [Related]
15. Potential doubling time and clinical outcome in head and neck squamous cell carcinoma treated with 70 GY in 7 weeks.
Bourhis J; Dendale R; Hill C; Bosq J; Janot F; Attal P; Fortin A; Marandas P; Schwaab G; Wibault P; Malaise EP; Bobin S; Luboinski B; Eschwege F; Wilson G
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):471-6. PubMed ID: 8655369
[TBL] [Abstract][Full Text] [Related]
16. Proliferative characteristics of head and neck tumors. In vivo evaluation by bromodeoxyuridine incorporation and flow cytometry.
Benazzo M; Mevio E; Occhini A; Franchini G; Danova M
ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):39-43. PubMed ID: 7700609
[TBL] [Abstract][Full Text] [Related]
17. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Guenzi M; Margarino G; Bacigalupo A; Garaventa G; Barbieri M
J Clin Oncol; 1995 Aug; 13(8):1843-50. PubMed ID: 7636527
[TBL] [Abstract][Full Text] [Related]
18. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
[TBL] [Abstract][Full Text] [Related]
19. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
20. Measurement of in vivo urological tumour cell kinetics using multiparameter flow cytometry. Preliminary study.
Rew DA; Thomas DJ; Coptcoat M; Wilson GD
Br J Urol; 1991 Jul; 68(1):44-8. PubMed ID: 1873691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
